|
1
|
Zheng J, Lin Z, Dong P, et al: Activation
of hepatic stellate cells is suppressed by microRNA-150. Int J Mol
Med. 32:17–24. 2013.PubMed/NCBI
|
|
2
|
Zheng J, Dong P, Gao S, Wang N and Yu F:
High expression of serum miR-17-5p associated with poor prognosis
in patients with hepatocellular carcinoma. Hepatogastroenterology.
60:549–552. 2013.PubMed/NCBI
|
|
3
|
Zheng J, Wu C, Lin Z, et al: Curcumin
up-regulates phosphatase and tensin homologue deleted on chromosome
10 through microRNA-mediated control of DNA methylation - a novel
mechanism suppressing liver fibrosis. FEBS J. 281:88–103. 2014.
View Article : Google Scholar
|
|
4
|
Huang B and Zhang R: Regulatory non-coding
RNAs: revolutionizing the RNA world. Mol Biol Rep. Feb
19–2014.(Epub ahead of print).
|
|
5
|
Gehrau RC, Mas VR, Villamil FG, et al:
MicroRNA signature at the time of clinical HCV recurrence
associates with aggressive fibrosis progression post-liver
transplantation. Am J Transplant. 13:729–737. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dong P, Yu F, Fan X, Lin Z, Chen Y and Li
J: Inhibition of ATIR by shRNA prevents collagen synthesis in
hepatic stellate cells. Mol Cell Biochem. 344:195–202. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gomes AQ, Nolasco S and Soares H:
Non-coding RNAs: multi-tasking molecules in the cell. Int J Mol
Sci. 14(8): 16010–16039. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao SM, Xing CY, Chen CQ, Lin SS, Dong PH
and Yu FJ: miR-15a and miR-16-1 inhibit the proliferation of
leukemic cells by down-regulating WT1 protein level. J Exp Clin
Cancer Res. 30(110)2011.PubMed/NCBI
|
|
9
|
Yu FJ, Dong PH, Fan XF, Lin Z, Chen YP and
Li J: Downregulation of angiotensin II by shRNA reduces collagen
synthesis in hepatic stellate cells. Int J Mol Med. 25:801–806.
2010.PubMed/NCBI
|
|
10
|
Chen SL, Zheng MH, Yang T, Song M and Chen
YP: Disparate profiles of dys-regulated miRNAs in activated hepatic
stellate cells. Hepatology. 57:1285–1286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kitagawa M, Kotake Y and Ohhata T: Long
noncoding RNAs involved in cancer development and cell fate
determination. Curr Drug Targets. 13:1616–1621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoon JH, Abdelmohsen K, Srikantan S, et
al: LincRNA-p21 suppresses target mRNA translation. Mol Cell.
47:648–655. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoon JH, Abdelmohsen K and Gorospe M:
Posttranscriptional gene regulation by long noncoding RNA. J Mol
Biol. 425:3723–3730. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Q, Chen CY, Yedavalli VS and Jeang
KT: NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1
post-transcriptional expression. MBio. 4:e00596–e00512. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiu MT, Hu JW, Yin R and Xu L: Long
noncoding RNA: an emerging paradigm of cancer research. Tumour
Biol. 34:613–620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Danko CG, Hah N, Luo X, et al: Signaling
pathways differentially affect RNA polymerase II initiation,
pausing, and elongation rate in cells. Mol Cell. 50:212–222. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moran VA, Perera RJ and Khalil AM:
Emerging functional and mechanistic paradigms of mammalian long
non-coding RNAs. Nucleic Acids Res. 40:6391–6400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gibb EA, Vucic EA, Enfield KS, et al:
Human cancer long non-coding RNA transcriptomes. PLoS One.
6:e259152011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bussemakers MJ, van Bokhoven A, Verhaegh
GW, et al: DD3: a new prostate-specific gene, highly overexpressed
in prostate cancer. Cancer Res. 59:5975–5979. 1999.PubMed/NCBI
|
|
20
|
van Devondervoort II, Gordebeke PM,
Khoshab N, et al: Long non-coding RNAs in neurodevelopmental
disorders. Front Mol Neurosci. 6(53)2013.PubMed/NCBI
|
|
21
|
Gutschner T and Diederichs S: The
hallmarks of cancer: a long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weikard R, Hadlich F and Kuehn C:
Identification of novel transcripts and noncoding RNAs in bovine
skin by deep next generation sequencing. BMC Genomics. 14(789)2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Yang L and Chen LL: Life without
A tail: new formats of long noncoding RNAs. Int J Biochem Cell
Biol. Oct 26–2013.(Epub ahead of print). View Article : Google Scholar
|
|
24
|
Nadal-Ribelles M, Solé C, Xu Z, Steinmetz
LM, de Nadal E and Posas F: Control of Cdc28 CDK1 by a
stress-induced lncRNA. Mol Cell. 53:549–561. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Imamura K, Imamachi N, Akizuki G, et al:
Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter
region to paraspeckle mediates IL8 expression upon immune stimuli.
Mol Cell. 53:393–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang F, Yi F, Han X, Du Q and Liang Z:
MALAT-1 interacts with hnRNP C in cell cycle regulation. J FEBS
Lett. 587:3175–3181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: a new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lai MC, Yang Z, Zhou L, et al: Long
non-coding RNA MALAT-1 overexpression predicts tumor recurrence of
hepatocellular carcinoma after liver transplantation. Med Oncol.
29:1810–1816. 2012. View Article : Google Scholar
|
|
30
|
Rinn JL, Kertesz M, Wang JK, et al:
Functional demarcation of active and silent chromatin domains in
human HOX loci by noncoding RNAs. Cell. 129:1311–1323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sørensen KP, Thomassen M, Tan Q, et al:
Long non-coding RNA HOTAIR is an independent prognostic marker of
metastasis in estrogen receptor-positive primary breast cancer.
Breast Cancer Res Treat. 142:529–536. 2013.PubMed/NCBI
|
|
32
|
Zhang JX, Han L, Bao ZS, et al: HOTAIR, a
cell cycle-associated long noncoding RNA and a strong predictor of
survival, is preferentially expressed in classical and mesenchymal
glioma. Neuro Oncol. 15:1595–1603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen FJ, Sun M, Li SQ, et al: Upregulation
of the long non-coding RNA HOTAIR promotes esophageal squamous cell
carcinoma metastasis and poor prognosis. Mol Carcinog. 52:908–915.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ishibashi M, Kogo R, Shibata K, et al:
Clinical significance of the expression of long non-coding RNA
HOTAIR in primary hepatocellular carcinoma. Oncol Rep. 29:946–950.
2013.PubMed/NCBI
|
|
35
|
Geng YJ, Xie SL, Li Q, Ma J and Wang GY:
Large intervening non-coding RNA HOTAIR is associated with
hepatocellular carcinoma progression. J Int Med Res. 39:2119–2128.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang Z, Zhou L, Wu LM, et al:
Overexpression of long non-coding RNA HOTAIR predicts tumor
recurrence in hepatocellular carcinoma patients following liver
transplantation. Ann Surg Oncol. 18:1243–1250. 2011. View Article : Google Scholar
|
|
37
|
Matouk I, Raveh E, Ohana P, et al: The
increasing complexity of the oncofetal h19 gene locus: functional
dissection and therapeutic intervention. Int J Mol Sci.
14:4298–4316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ratajczak MZ: Igf2-H19, an imprinted
tandem gene, is an important regulator of embryonic development, a
guardian of proliferation of adult pluripotent stem cells, a
regulator of longevity, and a ‘passkey’ to cancerogenesis. Folia
Histochem Cytobiol. 50:171–179. 2012.PubMed/NCBI
|
|
39
|
Necsulea A, Soumillon M, Warnefors M, et
al: The evolution of lncRNA repertoires and expression patterns in
tetrapods. Nature. 505:635–640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Monnier P, Martinet C, Pontis J, Stancheva
I, Ait-Si-Ali S and Dandolo L: H19 lncRNA controls gene expression
of the imprinted gene network by recruiting MBD1. Proc Natl Acad
Sci USA. 110:20693–20698. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu LL, Chang K, Lu LS, et al:
Lentivirus-mediated RNA interference targeting the H19 gene
inhibits cell proliferation and apoptosis in human choriocarcinoma
cell line JAR. BMC Cell Biol. 14(26)2013.PubMed/NCBI
|
|
42
|
Gao T, He B, Pan Y, et al: H19 DMR
methylation correlates to the progression of esophageal squamous
cell carcinoma through IGF2 imprinting pathway. Clin Transl Oncol.
16:410–417. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu
J: Upregulated H19 contributes to bladder cancer cell proliferation
by regulating ID2 expression. FEBS J. 280:1709–1716. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Matouk IJ, DeGroot N, Mezan S, et al: The
H19 non-coding RNA is essential for human tumor growth. PLoS One.
2:e8452007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang L, Yang F, Yuan JH, et al:
Epigenetic activation of the MiR-200 family contributes to
H19-mediated metastasis suppression in hepatocellular carcinoma.
Carcinogenesis. 34:577–586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yoshimizu T, Miroglio A, Ripoche MA, et
al: The H19 locus acts in vivo as a tumor suppressor. Proc Natl
Acad Sci USA. 105:12417–12422. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kameswaran V, Bramswig NC, McKenna LB, et
al: Epigenetic regulation of the DLK1-MEG3 microRNA cluster in
human type 2 diabetic islets. Cell Metab. 19:135–145. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tran DA, Bai AY, Singh P, Wu X and Szabo
PE: Characterization of the imprinting signature of mouse embryo
fibroblasts by RNA deep sequencing. Nucleic Acids Res.
42:1772–1783. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Benetatos L, Voulgaris E and Vartholomatos
G: DLK1-MEG3 imprinted domain microRNAs in cancer biology. Crit Rev
Eukaryot Gene Expr. 22:1–15. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Qin R, Chen Z, Ding Y, Hao J, Hu J and Guo
F: Long non-coding RNA MEG3 inhibits the proliferation of cervical
carcinoma cells through the induction of cell cycle arrest and
apoptosis. Neoplasma. 60:486–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ying L, Huang Y, Chen H, et al:
Downregulated MEG3 activates autophagy and increases cell
proliferation in bladder cancer. Mol Biosyst. 9:407–411. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Balik V, Srovnal J, Sulla I, et al: MEG3:
a novel long noncoding potentially tumour-suppressing RNA in
meningiomas. J Neurooncol. 112:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: a tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Braconi C, Kogure T, Valeri N, et al:
microRNA-29 can regulate expression of the long non-coding RNA gene
MEG3 in hepatocellular cancer. Oncogene. 30:4750–4756. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Anwar SL, Krech T, Hasemeier B, et al:
Loss of imprinting and allelic switching at the DLK1-MEG3 locus in
human hepatocellular carcinoma. PLoS One. 7:e494622012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
He Y, Meng XM, Huang C, et al: Long
noncoding RNAs: novel insights into hepatocelluar carcinoma. Cancer
Lett. 344:20–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Avellino AM, Grant GA, Harris AB, Wallace
SK and Shaw CM: Recurrent intracranial Masson's vegetant
intravascular hemangioendothelioma. Case report and review of the
literature. J Neurosurg. 91:308–312. 1999.
|
|
58
|
Yuan SX, Yang F, Yang Y, et al: Long
noncoding RNA associated with microvascular invasion in
hepatocellular carcinoma promotes angiogenesis and serves as a
predictor for hepatocellular carcinoma patients' poor
recurrence-free survival after hepatectomy. Hepatology.
56:2231–2241. 2012.PubMed/NCBI
|
|
59
|
Zhao Y, Guo Q, Chen J, Hu J, Wang S and
Sun Y: Rol. of long non-coding RNA HULC in cell proliferation,
apoptosis and tumor metastasis of gastric cancer: a clinical and
in vitro investigation. Oncol Rep. 31:358–364.
2014.PubMed/NCBI
|
|
60
|
Panzitt K, Tschernatsch MM, Guelly C, et
al: Characterization of HULC, a novel gene with striking
up-regulation in hepatocellular carcinoma, as noncoding RNA.
Gastroenterology. 132:330–342. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Xie H, Ma H and Zhou D: Plasma HULC as a
promising novel biomarker for the detection of hepatocellular
carcinoma. Biomed Res Int. 2013(136106)2013.PubMed/NCBI
|
|
62
|
Matouk IJ, Abbasi I, Hochberg A, Galun E,
Dweik H and Akkawi M: Highly upregulated in liver cancer noncoding
RNA is overexpressed in hepatic colorectal metastasis. Eur J
Gastroenterol Hepatol. 21:688–692. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wang J, Liu X, Wu H, et al: CREB
up-regulates long non-coding RNA, HULC expression through
interaction with microRNA-372 in liver cancer. Nucleic Acids Res.
38:5366–5383. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Liu Y, Pan S, Liu L, et al: A genetic
variant in long non-coding RNA HULC contributes to risk of
HBV-related hepatocellular carcinoma in a Chinese population. PLoS
One. 7:e351452012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Du Y, Kong G, You X, et al: Elevation of
highly up-regulated in liver cancer (HULC) by hepatitis B virus X
protein promotes hepatoma cell proliferation via down-regulating
p18. J Biol Chem. 287:26302–26311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Huang JF, Guo YJ, Zhao CX, et al:
Hepatitis B virus X protein (HBx)-related long noncoding RNA
(lncRNA) down-regulated expression by HBx (Dreh) inhibits
hepatocellular carcinoma metastasis by targeting the intermediate
filament protein vimentin. Hepatology. 57:1882–1892. 2013.
View Article : Google Scholar
|
|
67
|
Yang F, Zhang L, Huo XS, et al: Long
noncoding RNA high expression in hepatocellular carcinoma
facilitates tumor growth through enhancer of zeste homolog 2 in
humans. Hepatology. 54:1679–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Yang H, Zhong Y, Xie H, et al: Induction
of the liver cancer-down-regulated long noncoding RNA uc002mbe.2
mediates trichostatin-induced apoptosis of liver cancer cells.
Biochem Pharmacol. 85:1761–1769. 2013. View Article : Google Scholar : PubMed/NCBI
|
